Skip to main content

Advertisement

SpringerLink
Log in

CT Scan is not Everything in the Evaluation of a Patient with Gastrointestinal Tumors (GIST) Under Imatinib Therapy

  • Letter to Editor
  • Published:
Pathology & Oncology Research

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Stroszczynski C, Jost D, Reichardt P, Chmelik P, Gaffke G, Kretzschmar A et al (2005) Follow-up of gastrointestinal stromal tumours(GIST) during treatment with imatinib mesylate by abdominal MRI. Eur Radiol 15:2448–2456

    Article  PubMed  Google Scholar 

  2. Demetri GD, von Mehren M, Blanke CD, Van den Abbeele AD, Eisenberg B, Roberts PJ et al (2002) Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 347:472–480

    Article  PubMed  CAS  Google Scholar 

  3. Phongkitkarun S, Phaisanphrukkun C, Jatchavala J, Sirachainan E (2008) Assessment of gastrointestinal stromal tumors with computed tomography following treatment with imatinib mesylate. World J Gastroenterol 14:892–898

    Article  PubMed  CAS  Google Scholar 

  4. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205–216

    Article  PubMed  CAS  Google Scholar 

  5. Choi H, Charnsangavej C, de Castro Faria S, Tamm EP, Benjamin RS, Johnson MM et al (2004) CT Evaluation of the response of gastrointestinal stromal tumors after Imatinib Mesylate treatment: a quantitative analysis correlated with FDG PET findings. AJR Am J Roentgenol 183:1619–1628

    PubMed  Google Scholar 

  6. Benjamin RS, Choi H, Macapinlac HA, Burgess MA, Patel SR, Chen LL et al (2007) We should desist using RECIST, at Least in GIST. J Clin Oncol 25:1760–1764

    Article  PubMed  Google Scholar 

  7. Choi H, Charnsangavej C, Faria SC, Macapinlac HA, Burgess MA, Patel SR et al (2007) Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. J Clin Oncol 25:1753–1759

    Article  PubMed  Google Scholar 

  8. Jager PL, Gietema JA, van der Graaf WT (2004) Imatinib mesylate for the treatment of gastrointestinal stromal tumours: best monitored with FDG PET. Nucl Med Commun 25:433–438

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abdominal Department, Fudan University Shanghai Cancer Center, 270 Dong’an Road, Shanghai, 200032, People’s Republic of China

    C. M. Wang, H. Fu, G. F. Zhao & Y. Q. Shi

  2. Pathology Department, Cancer Center, Fudan University Shanghai Cancer Center, 270 Dong’an Road, Shanghai, 200032, People’s Republic of China

    J. Wang

  3. Department of Oncology, Shanghai Medical College, Fudan University Shanghai Cancer Center, 270 Dong’an Road, Shanghai, 200032, People’s Republic of China

    C. M. Wang, H. Fu, G. F. Zhao, J. Wang & Y. Q. Shi

Authors
  1. C. M. Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. F. Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Y. Q. Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Y. Q. Shi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, C.M., Fu, H., Zhao, G.F. et al. CT Scan is not Everything in the Evaluation of a Patient with Gastrointestinal Tumors (GIST) Under Imatinib Therapy. Pathol. Oncol. Res. 18, 1095–1097 (2012). https://doi.org/10.1007/s12253-011-9445-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-011-9445-0

Keywords

Search

Navigation